There is increasing evidence that anti-HBc-positive/HBsAg-negative patients (with or without HIV infection) are characterized by an increased progression of hepatic fibrosis, end-stage liver diseases, and at risk of HBV reactivation under severe immunosuppression [3,12,32,33,34,35]. Here, KRT88P is linked to HIV infectious disease.